Orlandi, Cesare,Clark, David J.,Grimes, Imogene M.,Valcarce Lopez, Maria Carmen,Kostura, Matthew J.
申请号：
AU2018203434
公开号：
AU2018203434A1
申请日:
2018.05.16
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018203434A120180607.pdf#####ABSTRACT The present invention relates to methods of treatment using [3-(4-{2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl amine ("COMPOUND I") or a pharmaceutically acceptable salt thereof. In various embodiments, the methods of treatment include treatment of mild-to-moderate dementia of Alzheimer's type, diabetes, insomnia, and other indications. The present invention also relates to pharmaceutical compositions comprising COMPOUND I or a pharmaceutically acceptable salt thereof. See Fig. 1.WO 2014/055588 PCT/US2013/062964 1/14 cio 0 c,4E 31 Q) L CD w r- Co LO -q- POC 6O-S~aV U! 96UDHO UDN
